Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Effect of ROSE-010 on Gastrointestinal Motor Functions in Female Patients With Constipation Predominant Irritable Bowel Syndrome (C-IBS)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01056107
Title field or adapter rule
{'original_value': 'Effect of ROSE-010 on Gastrointestinal Motor Functions in Female Patients With Constipation Predominant Irritable Bowel Syndrome (C-IBS)', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:35.356454+00:00
Published At
2013-05-31T00:00:00+00:00
Record Updated At
2013-05-31
Results Posted At
2013-05-31
Source Retrieved At
2026-10-31T22:18:50.761385+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Irritable Bowel Syndrome Constipation Predominant"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2013-05-31", "type": "ESTIMATED"}
protocolSection.identificationModule.nctId
"NCT01056107"
protocolSection.identificationModule.officialTitle
"Effect of ROSE-010 on Gastrointestinal Motor Functions in Female Patients With Constipation Predominant Irritable Bowel Syndrome (C-IBS)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct
{"date": "2013-05-31", "type": "ESTIMATED"}

Study condition terms

  • Irritable Bowel Syndrome Constipation Predominant (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['ROSE-010 100 mcg', 'ROSE-010 30 mcg', 'ROSE-010 300 mcg'], 'description': 'The study medication was used in 30 mcg, 100 mcg, and 300 mcg subcutaneous injections daily, depending upon study arm.', 'name': 'ROSE-010', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Placebo'], 'description': 'Placebo subcutaneous injection daily', 'name': 'Placebo', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • ROSE-010 (protocolSection.armsInterventionsModule.interventions[].name)
  • Placebo (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.